Definitive Healthcare Corp.
DH
Positions held
Your positionsDH isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $103.15M | Enterprise value | $129.61M | Trailing P/E | — | Forward P/E | 5.18 |
| PEG | — | Price / book | 0.71 | Beta | 1.40 | Dividend yield | 0.00% |
| Revenue growth | -9.1% | Earnings growth | — | Gross margin | 83.8% | Operating margin | -8.6% |
| Profit margin | -72.3% | ROE | -78.4% | ROA | -1.9% | Debt / equity | 0.89 |
| Current ratio | 1.86 | Free cash flow | $50.35M | Analyst recommendation | none | Mean target | $1.90 |
| 52w high | $3.15 | 52w low | $0.61 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $55.2M | $55.9M | $61.5M | $60.0M | $60.8M | — |
| Op margin | -8.6% | -8.6% | -10.9% | -5.6% | -5.8% | — |
| Net income | -$5.4M | -$139M | -$9.3M | -$14.8M | -$7.6M | — |
| Gross margin | 73.5% | 74.5% | 76.2% | 76.6% | 76.7% | — |
| Gross profit | $40.5M | $41.6M | $46.9M | $46.0M | $46.6M | — |
| Operating income | -$4.7M | -$4.8M | -$6.7M | -$3.4M | -$3.5M | — |
- Revenue -1% vs prior quarter ($55M vs $56M).
- Gross margin 73.5% (was 74.5% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $242M | $252M | $251M | $223M | — |
| Op margin | -8.5% | -3.9% | -12.3% | -16.2% | — |
| Net income | -$139M | -$413M | -$202M | -$7.2M | — |
| Gross margin | 75.9% | 78.3% | 81.1% | 80.9% | — |
| Gross profit | $183M | $197M | $204M | $180M | — |
| Operating income | -$20.6M | -$9.7M | -$30.9M | -$36.2M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-02 · Definitive Healthcare Shares Rise 13% After Advent International Submits $1.02-Per-Share Proposal
2026-09-02 · Definitive Healthcare Receives Acquisition Proposal From Advent International
2026-09-02 · Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International
2026-09-02 · Definitive Healthcare Appoints Clay Ritchey as CEO
2026-09-02 · Definitive Healthcare Appoints Clay Ritchey as CEO
2026-08-18 · Definitive Healthcare (DH) Q2 2026 Earnings Call
2026-08-12 · Deutsche Bank Adjusts Definitive Healthcare Price Target to $1 From $3, Maintains Hold Rating
2026-08-11 · Definitive Healthcare Corp. Q2 2026 Earnings Call Summary
2026-08-11 · Morgan Stanley Adjusts Definitive Healthcare PT to $1.50 From $2.50, Maintains Equalweight Rating
2026-08-11 · Definitive Healthcare Corp (DH) (Q2 2026) Earnings Call Highlights: AI Platform Launch and ...
2026-08-10 · Definitive Healthcare Q2 Earnings Call Highlights
Price (daily)
Full chart · RSI · MACD · patterns